218 related articles for article (PubMed ID: 35710421)
21. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC.
Yeh SH; Li CL; Lin YY; Ho MC; Wang YC; Tseng ST; Chen PJ
Cell Mol Gastroenterol Hepatol; 2023; 15(4):921-929. PubMed ID: 36690297
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
25. Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma.
Ren H; Chen X; Wang J; Chen Y; Hafiz A; Xiao Q; Fu S; Madireddy A; Li WV; Shi X; Cao J
J Med Virol; 2023 Oct; 95(10):e29187. PubMed ID: 37877809
[TBL] [Abstract][Full Text] [Related]
26. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Zhao LH; Liu X; Yan HX; Li WY; Zeng X; Yang Y; Zhao J; Liu SP; Zhuang XH; Lin C; Qin CJ; Zhao Y; Pan ZY; Huang G; Liu H; Zhang J; Wang RY; Yang Y; Wen W; Lv GS; Zhang HL; Wu H; Huang S; Wang MD; Tang L; Cao HZ; Wang L; Lee TL; Jiang H; Tan YX; Yuan SX; Hou GJ; Tao QF; Xu QG; Zhang XQ; Wu MC; Xu X; Wang J; Yang HM; Zhou WP; Wang HY
Nat Commun; 2016 Oct; 7():12992. PubMed ID: 27703150
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.
Chen W; Zhang K; Dong P; Fanning G; Tao C; Zhang H; Guo S; Wang Z; Hong Y; Yang X; Lai S; Ding H; Zhao H; Zeng C; Protzer U; Zhang D
Hepatol Int; 2020 May; 14(3):326-337. PubMed ID: 32100258
[TBL] [Abstract][Full Text] [Related]
28. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma.
Li X; Zhang J; Yang Z; Kang J; Jiang S; Zhang T; Chen T; Li M; Lv Q; Chen X; McCrae MA; Zhuang H; Lu F
J Hepatol; 2014 May; 60(5):975-84. PubMed ID: 24362074
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
30. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis.
Miao R; Luo H; Zhou H; Li G; Bu D; Yang X; Zhao X; Zhang H; Liu S; Zhong Y; Zou Z; Zhao Y; Yu K; He L; Sang X; Zhong S; Huang J; Wu Y; Miksad RA; Robson SC; Jiang C; Zhao Y; Zhao H
J Hepatol; 2014 Oct; 61(4):840-9. PubMed ID: 24859455
[TBL] [Abstract][Full Text] [Related]
32. The integration model of hepatitis B virus genome in hepatocellular carcinoma cells based on high-throughput long-read sequencing.
Li W; Wei W; Hou F; Xu H; Cui X
Genomics; 2022 Jan; 114(1):23-30. PubMed ID: 34843903
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.
Lee WY; Bachtiar M; Choo CCS; Lee CG
Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774
[TBL] [Abstract][Full Text] [Related]
34. MCM3AP, a novel HBV integration site in hepatocellular carcinoma and its implication in hepatocarcinogenesis.
Wang J; Lin J; Chang Y; Li P; Yang Y
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):425-9. PubMed ID: 20714864
[TBL] [Abstract][Full Text] [Related]
35. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma.
Robinson WS; Klote L; Aoki N
J Med Virol; 1990 May; 31(1):18-32. PubMed ID: 2165515
[TBL] [Abstract][Full Text] [Related]
36. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
[TBL] [Abstract][Full Text] [Related]
37. The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients.
Zheng B; Liu XL; Fan R; Bai J; Wen H; Du LT; Jiang GQ; Wang CY; Fan XT; Ye YN; Qian YS; Wang YC; Liu GJ; Deng GH; Shen F; Hu HP; Wang H; Zhang QZ; Ru LL; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Kong F; Chen JM; Zheng D; Yang Y; Wang CX; Wu L; Hou JL; Liu JF; Wang HY; Chen L
Clin Cancer Res; 2021 Jul; 27(13):3772-3783. PubMed ID: 33947693
[TBL] [Abstract][Full Text] [Related]
38. Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Jang JW; Kim JS; Kim HS; Tak KY; Nam H; Sung PS; Bae SH; Choi JY; Yoon SK; Roberts LR
Clin Mol Hepatol; 2021 Jan; 27(1):207-218. PubMed ID: 33317255
[TBL] [Abstract][Full Text] [Related]
39. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
40. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
